CCND1 and breast cancer: We found that PAF depletion downregulated β-catenin target genes (AXIN2, c-Myc and Cyclin D1) in breast cancer cells, recapitulating that PAF activates Wnt/β-catenin signalling17 (Figs 3g and 4j).